Source: FE Investegate

Midas Pharma: APONTIS PHARMA AG : APONTIS PHARMA: New development partnership with Midas Pharma - Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential

6:30 AM: APONTIS PHARMA: New development partnership with Midas Pharma - Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential

Read full article »
Midas Pharma's Competitors | Midas Pharma's News | Midas Pharma's Financials
Stay up-to-date with the latest news on Midas Pharma
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Karl-Heinz Schleicher's photo - President & CEO of Midas Pharma

President & CEO

Karl-Heinz Schleicher

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Midas Pharma